Early growth response 2 (EGR2) is a novel regulator of the senescence programme
Open Access
- 6 February 2021
- journal article
- research article
- Published by Wiley in Aging Cell
- Vol. 20 (3), e13318
- https://doi.org/10.1111/acel.13318
Abstract
Senescence, a state of stable growth arrest, plays an important role in ageing and age‐related diseases in vivo. Although the INK4/ARF locus is known to be essential for senescence programmes, the key regulators driving p16 and ARF transcription remain largely underexplored. Using siRNA screening for modulators of the p16/pRB and ARF/p53/p21 pathways in deeply senescent human mammary epithelial cells (DS HMECs) and fibroblasts (DS HMFs), we identified EGR2 as a novel regulator of senescence. EGR2 expression is up‐regulated during senescence, and its ablation by siRNA in DS HMECs and HMFs transiently reverses the senescent phenotype. We demonstrate that EGR2 activates the ARF and p16 promoters and directly binds to both the ARF and p16 promoters. Loss of EGR2 down‐regulates p16 levels and increases the pool of p16− p21− ‘reversed’ cells in the population. Moreover, EGR2 overexpression is sufficient to induce senescence. Our data suggest that EGR2 is a direct transcriptional activator of the p16/pRB and ARF/p53/p21 pathways in senescence and a novel marker of senescence.Keywords
Funding Information
- Medical Research Council (MR/K501372/1)
- U.S. Department of Energy (DE‐AC02‐05CH11231)
- Congressionally Directed Medical Research Programs
This publication has 53 references indexed in Scilit:
- Glucocorticoids delay RAF-induced senescence promoted by EGR1Journal of Cell Science, 2019
- Naturally occurring p16Ink4a-positive cells shorten healthy lifespanNature, 2016
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disordersNature, 2011
- Primary Cilium-Dependent and -Independent Hedgehog Signaling Inhibits p16INK4AMolecular Cell, 2010
- Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21Waf1/Cip1Oncogene, 2010
- Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferationGlia, 2005
- Reversal of human cellular senescence: roles of the p53 and p16 pathwaysThe EMBO Journal, 2003
- TBX-3, the Gene Mutated in Ulnar-Mammary Syndrome, Is a Negative Regulator of p19 and Inhibits SenescenceOnline Journal of Public Health Informatics, 2002
- Egr transcription factors in the nervous systemNeurochemistry International, 1997
- Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblastsProceedings of the National Academy of Sciences of the United States of America, 1996